PIN66 COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME-AVIBACTAM VERSUS COLISTIN-MEROPENEM IN THE TREATMENT OF INFECTIONS DUE TO CARBAPENEM-RESISTANT ENTEROBACTERIACEAE IN COLOMBIA
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1307
https://www.valueinhealthjournal.com/article/S1098-3015(19)33685-X/fulltext
Title :
PIN66 COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME-AVIBACTAM VERSUS COLISTIN-MEROPENEM IN THE TREATMENT OF INFECTIONS DUE TO CARBAPENEM-RESISTANT ENTEROBACTERIACEAE IN COLOMBIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33685-X&doi=10.1016/j.jval.2019.09.1307
First page :
Section Title :
Open access? :
No
Section Order :
11142